DEA Guidance on Medication Assisted Treatment (MAT) Evaluations by Telephone

April 3, 2020

Normally, an Opioid Treatment Program (OTP) must conduct an in-person medical evaluation of a patient before prescribing or directly dispensing controlled substances, including buprenorphine; but the COVID-19 health emergency has caused regulating bodies to modify this requirement. Click here to read the full article.